US Patent

US10653662 — Methods of using low-dose doxepin for the improvement of sleep

Method of Use · Assigned to PROCOM ONE Inc · Expires 2027-05-18 · 1y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods of using low-dose doxepin to prevent early awakenings and improve sleep efficiency in hours 7 and 8 of a sleep period.

USPTO Abstract

Methods of preventing early awakenings, and improving sleep efficiency in hours 7 and 8 of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg).

Drugs covered by this patent

doxepin-hydrochloride (DOXEPIN HYDROCHLORIDE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-620`	—	doxepin-hydrochloride
`U-620`	—	doxepin-hydrochloride

Patent Metadata

Patent number: US10653662
Jurisdiction: US
Classification: Method of Use
Expires: 2027-05-18
Drug substance claim: No
Drug product claim: No
Assignee: PROCOM ONE Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.